C4 Therapeutics Eulerpool Nieuws

C4 Therapeutics Eulerpool News

C4 Therapeutics Aandeel Nieuws

C4 Therapeutics wordt door vele journalisten en beleggers wereldwijd gevolgd. De meest actuele C4 Therapeutics nieuwsberichten verzamelen we hier.

• 16 september ·

  TipRanks
  Stifel Nicolaus Keeps Their Buy Rating on C4 Therapeutics (CCCC)
• 16 september ·

  TipRanks
  Cautious Hold Rating on C4 Therapeutics Amid Modest Efficacy and Pending Data
• 15 september ·

  TipRanks
  Hold Rating on C4 Therapeutics Amid Early-Stage Drug Development and Market Caution
• 13 september ·

  Yahoo
  C4 Therapeutics Presents Monotherapy Data Demonstrating Proof of Mechanism and Early Evidence of Proof of Concept From Ongoing CFT1946 Phase 1 Trial in BRAF V600 Mutant Solid Tumors at the European Society for Medical Oncology (ESMO) Congress 2024
• 13 september ·

  Thefly.com
  C4 Therapeutics announces next steps for CFT1946
• 10 september ·

  Yahoo
  C4 Therapeutics Announces Delivery of Second Development Candidate to Biogen
• 10 september ·

  Stock Options Channel
  Interesting CCCC Call Options For September 20th
• 9 september ·

  Yahoo
  C4 Therapeutics to Present Preliminary CFT1946 Monotherapy Phase 1 Clinical Data at the European Society for Medical Oncology (ESMO) Congress 2024
• 4 september ·

  TipRanks
  C4 Therapeutics (CCCC) Gets a Buy from Stifel Nicolaus
• 3 september ·

  Yahoo
  C4 Therapeutics Appoints Veteran Biotechnology Leader Stephen Fawell, Ph.D. to Board of Directors